These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19183340)

  • 21. [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis].
    Timmer A
    Z Gastroenterol; 2007 Feb; 45(2):191-3. PubMed ID: 17304406
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of metformin in the management of NAFLD.
    Mazza A; Fruci B; Garinis GA; Giuliano S; Malaguarnera R; Belfiore A
    Exp Diabetes Res; 2012; 2012():716404. PubMed ID: 22194737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin levels in nonalcoholic fatty liver disease.
    Abenavoli L
    Metabolism; 2011 Dec; 60(12):e3. PubMed ID: 21917277
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.
    Duseja A; Murlidharan R; Bhansali A; Sharma S; Das A; Das R; Chawla Y
    Indian J Gastroenterol; 2004; 23(1):12-5. PubMed ID: 15106708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
    Lavine JE; Schwimmer JB; Molleston JP; Scheimann AO; Murray KF; Abrams SH; Rosenthal P; Sanyal AJ; Robuck PR; Brunt EM; Unalp A; Tonascia J;
    Contemp Clin Trials; 2010 Jan; 31(1):62-70. PubMed ID: 19761871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of medications for the management of patients with NAFLD.
    Mazzella N; Ricciardi LM; Mazzotti A; Marchesini G
    Clin Liver Dis; 2014 Feb; 18(1):73-89. PubMed ID: 24274866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fatty liver and raised gamma-GT: it can happen to abstainers, too].
    Bischoff A
    MMW Fortschr Med; 2002 Feb; 144(7):18. PubMed ID: 11887726
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug treatment of insulin resistance].
    Tenoutasse S
    Rev Med Brux; 2009; 30(2):126-8. PubMed ID: 19517913
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease.
    Inzucchi SE; Petersen KF; Shulman GI
    N Engl J Med; 2002 Sep; 347(10):768-9; author reply 768-9. PubMed ID: 12214631
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis.
    Geroldi D; Emanuele E
    Hepatology; 2010 Feb; 51(2):719. PubMed ID: 19918969
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.
    Lavine JE; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):129-30. PubMed ID: 16456401
    [No Abstract]   [Full Text] [Related]  

  • 33. Metformin in polycystic ovary syndrome.
    Fisken RA
    N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
    Loomba R; Lutchman G; Kleiner DE; Ricks M; Feld JJ; Borg BB; Modi A; Nagabhyru P; Sumner AE; Liang TJ; Hoofnagle JH
    Aliment Pharmacol Ther; 2009 Jan; 29(2):172-82. PubMed ID: 18945255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin sensitizers in nonalcoholic steatohepatitis.
    Harrison SA; Schenker S; Cusi K
    Hepatology; 2011 Apr; 53(4):1404-5; author reply 1405. PubMed ID: 21480350
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?
    Sanyal AJ
    Am J Gastroenterol; 2001 Feb; 96(2):274-6. PubMed ID: 11232664
    [No Abstract]   [Full Text] [Related]  

  • 37. Metformin in polycystic ovary syndrome.
    Mascitelli L; Pezzetta F; Goldstein MR
    N Engl J Med; 2008 Apr; 358(17):1867-8; author reply 1868. PubMed ID: 18437729
    [No Abstract]   [Full Text] [Related]  

  • 38. Thiazolidinediones for nonalcoholic steatohepatitis--promising but not ready for prime time.
    McCullough AJ
    N Engl J Med; 2006 Nov; 355(22):2361-3. PubMed ID: 17135591
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment of non-alcoholic steatohepatitis: the current evidence.
    Diakou MC; Liberopoulos EN; Mikhailidis DP; Tsianos EV; Burroughs AK; Elisaf MS
    Scand J Gastroenterol; 2007 Feb; 42(2):139-47. PubMed ID: 17327932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.